Vanderbilt Institute For Chemical Biology
-
Watch Now: Lab-to-Table Conversation ‘Biotech Entrepreneurship: Stories & Strategies’
Join the next Lab-to-Table conversation, “Biotech Entrepreneurship: Stories & Strategies” on March 26 at 11 a.m. CT. Read MoreMar 12, 2024
-
Vanderbilt biochemists discover breakthrough evolution-resistant compound to combat antibiotic resistance
Vanderbilt scientist Houra Merrikh led a team of researchers who discovered the first evolution-resistant chemical compound that prevents drug resistance development in bacteria. The compound is also a drug development platform that targets antimicrobial resistance during treatment of infections with antibiotics and evolution in general, Merrikh said. Read MoreMar 1, 2024
-
Vanderbilt biochemists discover breakthrough anti-evolution compound to combat antibiotic resistance
The World Health Organization ranks antimicrobial resistance as one of the top ten global health risks. Vanderbilt researchers led by Houra Merrikh identified the first anti-evolution compound that targets AMR during treatment of infections with antibiotics. Read MoreFeb 26, 2024
-
Register for 17th annual Vanderbilt Institute of Chemical Biology Symposium Aug. 12
The 17th annual Vanderbilt Institute of Chemical Biology Symposium, hosted by the Vanderbilt Institute of Chemical Biology and the Chemical Biology Association of Students, is scheduled for Thursday, Aug. 12, from 8:30 a.m. to 5:15 p.m. CT. The event is sponsored by Ancora Innovation, through Vanderbilt’s partnership with Deerfield Management, and will be broadcast remotely. Read MoreAug 9, 2021
-
Ancora Innovation proposal submissions open March 14
This is the second request for proposals to Ancora since Vanderbilt and Deerfield launched their collaboration in 2018 with a commitment from Deerfield of up to $65 million in initial funding over five years to support promising drug discovery research. Read MoreFeb 26, 2019